1 |
Saddoughi SA, Gencer S, Peterson YK, et al (2013). Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med, 5, 105-121.
DOI
|
2 |
Saeidnia S, Abdollahi M (2013). Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharm, 271, 49-63.
DOI
|
3 |
Sakurai T, He G, Matsuzawa A, et al (2008). Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell, 14, 156-65.
DOI
|
4 |
Sosa V, Moline T, Somoza R, et al (2013). Oxidative stress and cancer: an overview. Ageing Res Rev, 12, 376-90.
DOI
ScienceOn
|
5 |
Sun L, Wang H, Wang Z, et al (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell, 148, 213-27.
DOI
ScienceOn
|
6 |
Trachootham D, Alexandre J, Huang P (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov, 8, 579-91.
DOI
|
7 |
Tu HC, Ren D, Wang GX, et al (2009). The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. Proc Natl Acad Sci USA, 106, 1093-8.
DOI
|
8 |
Ullrich E, Bonmort M, Mignot G, et al (2008). Tumor stress, cell death and the ensuing immune response. Cell Death Differ, 15, 21-8.
DOI
|
9 |
Wang L, Du F, Wang X (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell, 133, 693-703.
DOI
ScienceOn
|
10 |
Welz PS, Wullaert A, Vlantis K, et al (2011). FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature, 477, 330-4.
DOI
|
11 |
Whelan RS KK, Wei AC, Chen Y, et al (2012). Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA, 109, 6566-71.
DOI
|
12 |
Zhang H, Zhou X, McQuade T, et al (2011). Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature, 471, 373-6.
DOI
|
13 |
Zheng Y, Humphry M, Maguire JJ, et al (2013). Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation. Immunity, 38, 285-95.
DOI
|
14 |
Zou W, Xu W, Huo H, et al (2001). Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J Neurosci Res, 64, 646-53.
DOI
|
15 |
Cho YS, Challa S, Moquin D, et al (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell, 137, 1112-23.
DOI
|
16 |
de Bruin EC, Medema JP (2008). Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev, 34, 737-49.
DOI
|
17 |
Duprez L, Takahashi N, Van Hauwermeiren F, et al (2011). RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity, 35, 908-18.
DOI
|
18 |
Fu D, Jordan JJ, Samson LD (2013). Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosis. Genes Dev, 27, 1089-1100.
DOI
|
19 |
Green DR, Oberst A, Dillon CP, et al (2011). RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell, 44, 9-16.
DOI
|
20 |
He S, Wang L, Miao L, et al (2009). Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell, 137, 1100-11.
DOI
|
21 |
Junttila MR, de Sauvage FJ (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature, 501, 346-54.
DOI
|
22 |
Kaczmarek A, Vandenabeele P, Krysko DV (2013). Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity, 38, 209-223.
DOI
ScienceOn
|
23 |
Krysko DV, Garg AD, Kaczmarek A, et al (2012). Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer, 12, 860-75.
DOI
|
24 |
Krysko DV, Vandenabeele P (2008). From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ, 15, 29-38.
DOI
|
25 |
Ku G, Tan IB, Yau T, et al (2012). Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol, 13, 470-481.
DOI
|
26 |
ME P. (2011). Programmed cell death: Apoptosis meets necrosis. Nature, 471, 310-2.
DOI
|
27 |
Motz GT, Coukos G (2013). Deciphering and reversing tumor immune suppression. Immunity, 39, 61-73.
DOI
|
28 |
Narayan N, Lee IH, Borenstein R, et al (2012). The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature, 492, 199-204.
DOI
|
29 |
Oberst A, Dillon CP, Weinlich R, et al (2011). Catalytic activity of the caspase-8-FLIP (L) complex inhibits RIPK3-dependent necrosis. Nature, 471, 363-7.
DOI
ScienceOn
|